Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRC-Pharma 001 for Local Analgesia in Intubation and Endoscopy
NCT00791024Phase 2Completed
- Start
- Nov 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of CRC-Pharma 001 in pain. Primary endpoint: Visual Analog Scale at 3 days. Started Nov 2008; status: completed.
02
Drugs
CRC-Pharma 001
03
Conditions
pain
Beyond the preview
Go deeper on NCT00791024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791024.